prulifloxacin
This page covers all prulifloxacin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Phase 3 pipeline (1)
- PRULIFLOXACIN · Infectious Disease
Prulifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication.
Patent intelligence
- prulifloxacin patent landscape — aggregated cliff calendar, attackable patents, originator estates